Immunization

AstraZeneca now offers FluMist Home, allowing eligible patients to receive and self-administer the flu vaccine entirely at home.

During National Immunization Awareness Month, Hashim Zaibak, PharmD, provided personal tips for community pharmacies looking to expand their vaccination services.

Exploring WHO National Immunization Technical Advisory Groups, researchers assessed the global adoption and trends of off-label vaccine use since the COVID-19 pandemic.

Investigators find a large burden of hospitalization due to community-acquired pneumonia (CAP) for adults in the US, mainly caused by Streptococcus pneumoniae.

Collaboration between pharmacists and primary care providers enhances RSV vaccine uptake by improving patient education and trust.

Understanding post-PREP implications is critical for evaluating current public health delivery, identifying ongoing access, and informing future policy.

As researchers continue to measure the impacts of the COVID-19 pandemic on public health, Hashim Zaibak, PharmD, discusses the evolution of community pharmacies in a postpandemic world.

Researchers conducted a systematic review to determine the effectiveness of pharmacists in promoting vaccine uptake for protection against the most prominent infectious diseases.

Novavax’s H5N1 avian influenza vaccine candidate shows a robust immune response with 1- and 2-dose intranasal or intramuscular administration for nonhuman primates.

Researchers in Kenya explored vaccination behaviors among individuals of various socioeconomic or educational statuses.

Among pediatric patients in Colombia, researchers explored the prevalence of bacterial acute otitis media caused by Streptococcus pneumoniae.

The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 lineage did not increase the risk of 29 adverse events of special interest.

Secretary of US Health and Human Services Robert F. Kennedy Jr also approved all recommendations issued from the April ACIP meeting.

Flu vaccination significantly reduces illness in vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

New study data reveal the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

The new presentation of Shingrix will allow for easier administration.

New research findings reveal amoxicillin's effectiveness varies in treating invasive pneumococcal disease, highlighting the importance of patient-specific factors in antibiotic therapy.

Older adults are more likely to have chronic diseases, such as lung or heart disease, which makes them more susceptible to invasive pneumococcal disease.

Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.

Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.

As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.

Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child, and 40% cite safety concerns.

ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.

Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.